Modal close

Dear Democracy Now! visitor,

You turn to Democracy Now! for ad-free news you can trust. Maybe you come for our daily headlines. Maybe you come for in-depth stories that expose corporate and government abuses of power. Democracy Now! brings you crucial reporting like our coverage from the front lines of the Dakota Access pipeline protests or news about this unprecedented US presidential election—and our coverage is never paid for by the oil and gas companies or the campaigns and superPACs. We produce our daily news hour at a fraction of the budget of a commercial news operation—all without ads, government funding or corporate sponsorship. How? This model of news depends on your support. Today, less than 1% of our visitors support Democracy Now! with a donation each year. If even 3% of our website visitors donated just $8 per month, we could cover our basic operating expenses for a year. Pretty amazing right? If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.

Topics

Monsanto's Revolving Door

July 23, 1999
Story
WATCH FULL SHOW

Last month, Monsanto’s G.D. Searle pharmaceuticals unit named Michael A.Friedman as its new clinical-research chief. In his new capacity, Dr. Friedman will direct strategy and execution of clinical research on new drugs at Searle. Friedman was acting commissioner of the FDA, the Food and Drug Administration, from February 1997 through November 1998, and also served as lead deputy operations commissioner of the federal agency. And from 1985 to 1995 he held senior positions at the National Cancer Institute. Donna Shalala, secretary of Health and Human Services, credited Friedman with having played a major role in speeding up FDA approval of cancer drugs.

But Dr. Friedman is not the only person to leave a government post for Monsanto. It seems that Monsanto and the Clinton Administration have a close relationship, a revolving door. A growing number of government officials are going to the biotech giant as lobbyists and officers in the company.

Guest:

  • Mike Hansen, researcher at Consumer Policy Institute, a division of Consumers Union, publisher of Consumer Reports. Call: 914.378.2452.

Related links:


The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.